RFG - Bristol Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.19M Buy
4,541
+9
+0.2% +$2.31K 0.28% 68
2026
Q2
$1.14M Sell
4,532
-2
-0% -$430 0.28% 72
2026
Q1
$986K Sell
4,534
-3
-0.1% -$665 0.27% 72
2025
Q4
$1.04M Sell
4,537
-125
-3% -$28.5K 0.29% 70
2025
Q3
$1.08M Buy
4,662
+2
+0% +$407 0.31% 69
2025
Q2
$865K Buy
4,660
+5
+0.1% +$929 0.27% 78
2025
Q1
$975K Buy
4,655
+174
+4% +$33.8K 0.33% 65
2024
Q4
$796K Buy
+4,481
New +$824K 0.26% 80

Other funds holding ABBV

RFG - Bristol Wealth Advisors's ABBV Position: Q3 2026 in Review

RFG - Bristol Wealth Advisors increased its AbbVie (ABBV) stake by 0.2% in Q3 2026, buying an estimated $2.31K and bringing the position to 4,541 shares worth $1.19M. The position accounts for 0.28% of the portfolio, ranked #68.

RFG - Bristol Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • RFG - Bristol Wealth Advisors held 4,541 shares of AbbVie worth $1.19M as of Q3 2026.
  • RFG - Bristol Wealth Advisors bought 9 AbbVie shares in Q3 2026, an estimated $2.31K.
  • AbbVie made up 0.28% of RFG - Bristol Wealth Advisors's portfolio in Q3 2026, its #68 holding.
  • RFG - Bristol Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on RFG - Bristol Wealth Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.